Costing of AMR can Incentivize Responses to One Health

Pushpam Kumar

doi:10.5334/aogh.5355

January 1, 2026Annals of Global HealthOpen Access

Costing of AMR can Incentivize Responses to One Health

View Full Paper

Ask AI

Bookmark

Share

Key Points

This research aims to highlight the necessity and feasibility of monetizing the impact of antimicrobial resistance (AMR).
Monetization of the damages caused by AMR.
Analysis of economic and social factors related to AMR.
Development of a framework for policy responses and interventions.
Clearer policy responses to AMR are achievable through proper costing.
Investment in necessary interventions is facilitated by understanding AMR costs.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Monetising the damage inflicted to economy and society is necessary and it is doable. The costing of antimicrobial resistance (AMR) enables clearer policy response and removes haziness in decisions. Costing the AMR facilitates the investment in interventions, needed for implementation of One Health.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Pushpam Kumar (2026) studied this question.

synapsesocial.com/papers/6a2ba3748101cf8926f0214d https://doi.org/10.5334/aogh.5355

View Full Paper

Ask AI

Bookmark

Share

Costing of AMR can Incentivize Responses to One Health

Key Points

Ask about this paper

Abstract

Discussion

Cite This Study

Costing of AMR can Incentivize Responses to One Health

Key Points

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading